- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.Bladder CancerJuly 1, 2026
-
Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder Cancer.Bladder CancerJuly 1, 2026
-
Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.Bladder CancerJuly 1, 2026
-
State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK).Bladder CancerJuly 1, 2026
-
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.Bladder CancerJune 30, 2026
-
Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancer.Bladder CancerJune 30, 2026
-
Complete pathological response in patients with bladder cancer: predictors and outcomes.Bladder CancerJune 30, 2026
-
Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer.Bladder CancerJune 29, 2026
-
BCG Induces PD-1 Upregulation on Circulating CD8+ T Cells and IL-6 and IL-8 Secretion In Vitro.Bladder CancerJune 29, 2026
-
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort Study.Bladder CancerJune 26, 2026
Beyond the Abstracts
-
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter - Beyond the AbstractBladder CancerJune 17, 2026
-
Impact of Asymptomatic Bacteriuria on the Outcomes and Tolerability of Bacillus Calmette-Guérin Immunotherapy - Beyond the AbstractBladder CancerJune 16, 2026
-
HER2 and Urothelial Carcinoma: Current Understanding and Future Directions - Beyond the AbstractBladder CancerJune 16, 2026
-
Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the AbstractBladder CancerMay 26, 2026
-
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design - Beyond the AbstractBladder CancerMay 22, 2026
-
Impact of Pelvic Lymph Node Dissection on Oncological Outcomes in Patients with Clinically Staged Non-Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Systematic Review - Beyond the AbstractBladder CancerMay 22, 2026
-
Population-Based Outcomes of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer in Older Adults - Beyond the AbstractBladder CancerMay 21, 2026
-
Advances and Challenges of PET Imaging in Bladder Cancer-an Update and Future Trends - Beyond the AbstractBladder CancerMay 20, 2026
-
Real-World Effectiveness of Avelumab, Pembrolizumab, and Enfortumab Vedotin in Patients with Advanced Urothelial Carcinoma with Squamous Differentiation (ARON-2EV) - Beyond the AbstractBladder CancerMay 14, 2026
-
Preferred Treatment Sequencing for Metastatic Urothelial Carcinoma (mUC) in the Era of Perioperative and First-Line (1L) Checkpoint Inhibitor: Results From a National Survey of Genitourinary Oncologists - Beyond the AbstractBladder CancerMay 7, 2026